Search | VHL Regional Portal

1.

Tratamiento hipometilante de los Síndromes Mielodisplásicos de la fisiopatogenia y la farmacología a la práctica clínica / Hypomethylation therapy for myelodisplastic Syndromes. From pathophysiology and pharmacology to clinical practice

Iastrebner, Marcelo; Flore, Alejandro; Benasayag, Silvia.

Hematología (B. Aires) ; 13(1): 16-28, ene.-abr. 2009. graf, tab

Article in Spanish | LILACS | ID: lil-547261

Subject(s)

Myelodysplastic Syndromes

2.

Tratamiento hipometilante de los Síndromes Mielodisplásicos de la fisiopatogenia y la farmacología a la práctica clínica / Hypomethylation therapy for myelodisplastic Syndromes. From pathophysiology and pharmacology to clinical practice

Iastrebner, Marcelo; Flore, Alejandro; Benasayag, Silvia.

Hematología (B. Aires) ; 13(1): 16-28, ene.-abr. 2009. graf, tab

Article in Spanish | BINACIS | ID: bin-124590

Subject(s)

Myelodysplastic Syndromes

3.

Conocimientos esenciales de biología molecular para médicos. Nuevos blancos terapéuticos / Essentials in molecular biology for physicians. New therapeutic targets

Benasayag, Silvia; Ponzinibbio, Carlos; Koziner, Benjamín; Fassi, Daniel; Iastrebner, Marcelo.

Hematología (B. Aires) ; 9(1): 17-27, ene.-abr. 2005. tab

Article in Spanish | LILACS | ID: lil-481607

Subject(s)

Hematology

4.

Conocimientos esenciales de biología molecular para médicos. Nuevos blancos terapéuticos / Essentials in molecular biology for physicians. New therapeutic targets

Benasayag, Silvia; Ponzinibbio, Carlos; Koziner, Benjamín; Fassi, Daniel; Iastrebner, Marcelo.

Hematología (B. Aires) ; 9(1): 17-27, ene.-abr. 2005. tab

Article in Spanish | BINACIS | ID: bin-122330

Subject(s)

Hematology

5.

Inv(4)(p14q27) in a case with de novo acute nonlymphocytic leukemia.

Benasayag, Silvia; Arias, Eugenia; Baialardo, Edgardo; Reyes, Myriam; Sapia, Sandra; Bistmans, Alicia; Slavutsky, Irma.

Acta Haematol ; 108(1): 39-42, 2002.

Article in English | MEDLINE | ID: mdl-12145466

ABSTRACT

An inversion, inv(4)(p14q27), was found as the sole karyotypic anomaly at diagnosis in the bone marrow cells from a 65-year-old male patient with an M4 acute nonlymphocytic leukemia (ANLL). To our knowledge, the breakpoints observed in this case appear to be different from other inversions of chromosome 4 previously described in ANLL. The patient we described had a poor response to chemotherapy and had a short survival.

Subject(s)

Chromosome Inversion , Chromosomes, Human, Pair 4/ultrastructure , Leukemia, Myelomonocytic, Acute/genetics , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bone Marrow/pathology , Chromosomes, Human, Pair 4/genetics , Cytarabine/administration & dosage , Fatal Outcome , Humans , Idarubicin/administration & dosage , Karyotyping , Leukemia, Myelomonocytic, Acute/drug therapy , Male , Mitoxantrone/administration & dosage

Subject(s)

Subject(s)

Subject(s)

Subject(s)

ABSTRACT

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL